Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy

Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy

<b>Objective:</b> This study’s objective was to evaluate the effects of pharmacokinetic and pharmacogenetic factors on major bleeding in patients with ACS and non-valvular AF receiving combined antithrombotic therapy consisting of rivaroxaban, clopidogrel, and aspirin as part of dual or...

Full description

Bibliographic Details
Main Authors: Olga Baturina, Maria Chashkina, Denis Andreev, Karin Mirzaev, Alexandra Bykova, Alexandr Suvorov, Daria Yeryshova, Svetlana Suchkova, Dmitry Sychev, Abram Syrkin
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Journal of Personalized Medicine
Subjects:
combined antithrombotic therapy
rivaroxaban
clopidogrel
dual antiplatelet therapy
triple antiplatelet therapy
atrial fibrillation
Online Access:https://www.mdpi.com/2075-4426/13/9/1371

Internet

https://www.mdpi.com/2075-4426/13/9/1371

Similar Items